Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called "superbugs" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs).
Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
It's been surprising how little of the technical side goes into a business plan and that's a big change in thinking from a lot of more technical founders, you know, your PhD students or engineering students, you know, that's really not what...People want a business plan and they want to assume that ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login